Publicaciones (40) Publicaciones en las que ha participado algún/a investigador/a

2004

  1. 12-Month comorbidity patterns and associated factors in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 28-37

  2. Abnormalities in the NF-κB family and related proteins in endometrial carcinoma

    Journal of Pathology, Vol. 204, Núm. 5, pp. 569-577

  3. Aproximación metodológica al uso de redes neuronales artificiales para la predicción de resultados en medicina

    Medicina Clinica, Vol. 122, Núm. SUPPL. 1, pp. 59-67

  4. Apunts metodológies sobre els models probabilístics

    Annals de Medicina, Vol. 87, Núm. 1, pp. 10-11

  5. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients

    Journal of Steroid Biochemistry and Molecular Biology

  6. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death

    Journal of Biological Chemistry, Vol. 279, Núm. 33, pp. 34882-34889

  7. Condensin Regulates rDNA Silencing by Modulating Nucleolar Sir2p

    Current Biology, Vol. 14, Núm. 2, pp. 125-130

  8. Customizing chemotherapy for colon cancer: The potential of gene expression profiling

    Drug Resistance Updates, Vol. 7, Núm. 3, pp. 209-218

  9. Disability and quality of life impact of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 38-46

  10. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status

    Human Molecular Genetics, Vol. 13, Núm. 19, pp. 2303-2311

  11. Evolution and cellular function of monothiol glutaredoxins: Involvement in iron-sulphur cluster assembly

    Comparative and Functional Genomics, Vol. 5, Núm. 4, pp. 328-341

  12. Genetic counseling program in familial breast cancer: Analysis of its effectiveness, cost and cost-effectiveness ratio

    International Journal of Cancer, Vol. 112, Núm. 4, pp. 647-652

  13. Glial cell line-derived neurotrophic factor increases intracellular calcium concentration: Role of calcium/calmodulin in the activation of the phosphatidylinositol 3-kinase pathway

    Journal of Biological Chemistry, Vol. 279, Núm. 7, pp. 6132-6142

  14. HGF promotes survival and growth of maturing sympathetic neurons by PI-3 kinase- and MAP kinase-dependent mechanisms

    Molecular and Cellular Neuroscience, Vol. 27, Núm. 4, pp. 441-452

  15. HGF regulates the development of cortical pyramidal dendrites

    Development, Vol. 131, Núm. 15, pp. 3717-3726

  16. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene

    Cancer Cell, Vol. 6, Núm. 3, pp. 263-274

  17. Initial immunoglobulin M 'Flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: An Eastern Cooperative Oncology Group Study

    Cancer, Vol. 101, Núm. 11, pp. 2593-2598

  18. Malignant peripheral nerve sheath tumor of the thyroid: A clinicopathological and ultrastructural study of one case

    Endocrine Pathology, Vol. 15, Núm. 2, pp. 167-174

  19. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

    British Journal of Cancer, Vol. 91, Núm. 11, pp. 1931-1946

  20. Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)

    Leukemia and Lymphoma, Vol. 45, Núm. 10, pp. 2047-2055